Clovis Oncology Inc. buy Traumtanz
Start price
29.01.21
/
70%
€6.91
Target price
€8.00
Performance (%)
16.27%
End price
06.02.21
€8.03
Summary
This prediction ended on 06.02.21 with a price of €8.03. The prediction had a final performance of 16.27%. Traumtanz has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Clovis Oncology Inc. | - | - | - | - |
| iShares Core DAX® | 0,99 % | 8,31 % | 7,03 % | 49,79 % |
| iShares Nasdaq 100 | 2,07 % | 16,77 % | 35,95 % | 96,63 % |
| iShares Nikkei 225® | 2,27 % | 15,61 % | 46,57 % | 69,05 % |
| iShares S&P 500 | 1,04 % | 11,08 % | 26,46 % | 68,09 % |
According to Traumtanz what are the pros and cons of Clovis Oncology Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Traumtanz for this prediction
In the thread Clovis Oncology Inc. diskutieren
